The Centers for Medicare & Medicaid Services (CMS) released an updated version of the Medicare Part D opioid prescribing mapping tool and a new Medicaid opioid prescribing mapping tool.
The Medicare Part D opioid prescribing mapping tool is an interactive, web-based visualization resource that presents geographic comparisons of opioid prescribing rates at the state, county, and ZIP code levels. The update to the Medicare Part D mapping tool now allows users to quickly compare Medicare Part D opioid prescribing rates in urban and rural areas at the state, county and ZIP code levels. In Medicare Part D, opioid prescribing rates at the state level in 2016 range from 2.9% to 7.4% compared to the national average opioid prescribing rate of 5.32%. Opioid prescribing is slightly higher in rural areas (5.47%) compared to urban areas (5.30%).
The Medicaid opioid prescribing mapping tool is a new interactive, web-based visualization resource that presents geographic comparisons at the state level of Medicaid opioid prescribing rates. The Medicaid mapping tool allows users to quickly compare Medicaid opioid prescribing rates overall and segmented by fee-for-service and managed care programs. In Medicaid, opioid prescribing rates at the state level in 2016 range from 2.9% to 9.4% compared to the national average opioid prescribing rate of 5.4%. Opioid prescribing is slightly higher in managed care (5.44%) compared to fee-for-service (5.29%).
Are you an authorized user of Rochester RHIO? Do you use the query portal to search for patient information? Or, do you receive RHIO patient alerts? By March 31, 2019, Rochester RHIO will begin including specially protected substance use and behavioral health care data (SAMHSA, Part 2) in its health information exchange. With patient consent, authorized users and medical professionals will be able to view this data immediately in a patient’s record enabling better patient care.
Crisis in America The opioid crisis has devastating effects on individuals, families, and communities across the United States. In 2017, 11.1 million Americans reported misuse of prescription opioids and nearly 900,000 reported heroin use. Responsible, secure sharing and use of this specially protected health information is a critical step in helping combat the opioid epidemic. The federal Substance Abuse and Mental Health Services Administration (SAMHSA) is leading efforts to support the implementation of the full range of prevention, treatment and recovery support services to advance behavioral health and reduce the impact of substance use disorders in America.
Why does this matter to me? As an authorized user of patient information via the Rochester RHIO, it is important to understand your responsibility to be compliant with all relevant federal and state-required changes to Part 2 data delivery.
What is SAMHSA, Part 2 data? The Substance Abuse and Mental Health Services Administration (SAMHSA) is a federal agency under the U.S. Department of Health and Human Services. SAMHSA, or Part 2, data is a term that applies to any service received at a federally-assisted facility, provider, or clinic for the treatment of a substance use disorder or behavioral health care.
Why is this change happening now? New York State is requiring that all regional health information organizations that comprise the SHIN-NY, including Rochester RHIO, include specially protected substance use disorder and behavioral health care data (Part 2) by March 31, 2019.
What if I have additional questions? If you have additional questions about specially protected substance use or behavioral health information (Part 2 data), you can contact your RHIO Account Manager. Or, call our Support Center at 1-877-865-7446 (RHIO).
Free Webinars:
Join us online for a 60-minute informational program on changes to specially protected substance use and behavioral health care data (Part 2) at Rochester RHIO. In this webinar, we'll explain the Part 2 data changes, how SAMHSA is different from HIPAA, and tips on how you can remain compliant while handling Part 2 data from the Rochester RHIO’s clinical query portal.
Register today:
The deadline to submit 2018 attestation data for the Promoting Interoperability Programs is February 28, 2019.
Last year, the Centers for Medicare & Medicaid Services (CMS) transitioned to the QualityNet System for hospitals that attest to CMS for the Promoting Interoperability Programs. By transitioning to one system, CMS continues the effort to streamline data submission methods and reduce burden.
Specific submission details for each program is listed below.
Registering on Behalf of a Medicaid EP?
An EP can designate a third party to register and attest on his or her behalf. To do so, users working on behalf of an EP must have an Identity and Access Management System (I&A) web user account (User ID/Password) and be associated with the EP’s National Provider Identifier (NPI). If you are working on behalf of one or more EPs and you do not have an I&A web user account, please visit I&A Security Check to create one.
Note: States and territories will not necessarily offer the same functionality for registration and attestation in the Promoting Interoperability Program. Check with your state or territory to see what functionality is offered.
Additional Resources
For More Information
Friday, March 15, 2019
8:00am - 4:00pm
Monroe Community Hospital, Rochester, NY
$20/ per person, includes lunch
For more information, click here.
Annual Legislative Breakfast
Friday, March 15th, 2019
8:30am to 10:30am
Doubletree by Hilton, 1111 Jefferson Road, Rochester, NY
For More Information click here.
Monday, March 11, 2019 1:00 PM - 2:00 PM EST
The Centers for Medicare & Medicaid Services (CMS) is hosting a webinar titled “Eligible Clinician New eCQMs Finalized for 2019” on March 11, 2019. This one-hour session will provide an in-depth review of the following new electronic clinical quality measures (eCQMs) finalized for the 2019 performance period: HIV Screening (CMS349) and Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture (CMS249). CMS has transitioned the logic used in eCQMs from the previous quality data model (QDM) logic expression language to Clinical Quality Language (CQL) for the 2019 performance year. This session will provide an introduction to the new eCQMs finalized for 2019 Merit-based Incentive Payment System (MIPS) Quality performance year. As a result of the feedback received from stakeholders interviewed through the CMS eCQM Strategy Project to reduce implementation and reporting burdens, this session is intended to prepare eligible clinicians, vendors, quality, and health information technology staff for eCQM reporting, and is the last in a series of five educational sessions to provide relevant information to support successful understanding, interpretation, and implementation of eCQMs.
At the end of this session, participants will be able to:
Registration link:
https://event.on24.com/wcc/r/1895034/5315F596B1380187E58FF089388717C3
Space is limited for this webinar. Registration will close when we have reached maximum capacity. This webinar will be recorded. If you are unable to participate, a replay of the webinar with presentation slides will be available on the eCQI Resource Center website within 2 weeks following the program.
DFS has decided to delay implementation of the recently updated WC Medical Fee Schedule until October 1, 2020 for the Auto No-Fault Program. Therefore, you will need to keep the WC fee schedule that was effective on June 1, 2012 for billing claims for the treatment of persons injured as the result of auto accidents.
Public comment should sent to Camielle.Barclay@dfs.ny.gov before April 22, 2019.
The Centers for Medicare & Medicaid Services (CMS) is currently updating the Promoting Interoperability Programs website to include new resources for the 2019 program year. Below are resources that are now available online:
In 2016 the American Medical Association (AMA) and a number of other health-related organizations partnered to establish Xcertia, with the goal of developing guidelines for safe and effective digital health apps that will facilitate virtual care, including remote patient monitoring for chronic diseases. This is an emerging set of technologies, which is largely unregulated. Many solutions are not evidence-based and have not demonstrated that they are safe and effective tools for use as part of a patient’s treatment plan. Xcertia has now released a complete set of guidelines covering the privacy, security, operability, usability and clinical content of mHealth solutions: https://xcertia.org/news-announcements/. The guidelines are now available for public comment until May 15, 2019 at: https://www.xcertia.org/the-guidelines/. Xcertia will rely on these public comments to create a final version of the guidelines. Xcertia welcomes your comments and encourages you to join with us in recommending the guidelines to developers and physicians as a resource when considering mHealth solutions for their practice and to recommend to their patients. For questions, comments or if you wish to join this effort, please contact Michael L Hodgkins, MD, VP & CMIO, AMA at michael.hodgkins@ama-assn.org.
March 14th, 2019, 8:30am - 1:00pm at the Telesca Center for Justice.
Don’t miss this valuable half-day training presented by the RMC/DVC’s Education Committee. Topics include:
